131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Conditions
- Sickling Disorder Due to Hemoglobin S
Interventions
- DRUG: 131I-apamistmab
- DRUG: Sirolimus
- DRUG: Campath
- DRUG: Total Body Irradiation
- PROCEDURE: Exchange Transfusion
- RADIATION: Planar gamma imaging
Sponsor
Columbia University
Collaborators